Noninterventional Observational Prospective Longitudinal Study of the Incidence of Ulcerative Colitis and Crohn's Disease Among the Adult Population of the Republic of Kazakhstan

NCT ID: NCT05189327

Last Updated: 2022-01-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

2000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-12-10

Study Completion Date

2024-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The NUCaCD study aims to develop a reliable registry of patients suffering inflammatory bowel diseases in the Republic of Kazakhstan.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The NUCaCD aims to study the prevalence of inflammatory bowel diseases in the Republic of Kazakhstan and create a reliable database, which will greatly facilitate future planning of the volume of health resources needed to address these diseases management and will help to optimize preventive measures and will support future research to better understand the etiology, new options treatment and factors affecting prognosis, relapses, development of complications and quality of life.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ulcerative Colitis Chronic Crohn Disease Colon

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients with diagnosed Nonspecific Ulcerative Colitis and Crohn Disease

All patients with diagnosed Nonspecific Ulcerative Colitis and Crohn Disease in the Republic of Kazakhstan.

No intervention

Intervention Type OTHER

Non-interventional study

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

No intervention

Non-interventional study

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Availability of a signed informed consent form; or the presence of a disinterested witness if the patient is unable to examine and sign the consent form due to illiteracy or disability (for example, in the case of blindness);
* The patient has a documented diagnosis of ulcerative colitis or Crohn's disease (endoscopy, histology, if indicated by radiation diagnostics);
* Patients who have applied for treatment or are already taking treatment from a gastroenterologist / coloproctologist, including inpatients;
* Citizenship of the Republic of Kazakhstan (or resides).

Exclusion Criteria

* Patient takes part in an interventional clinical trial;
* Patient is unable to follow the schedule of the visits;
* Any condition that the PI believes would prevent a study participant from participating in the study.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

FERRING Kazakhstan

UNKNOWN

Sponsor Role collaborator

Kazakhstan Scientific Society for Study of intestine diseases

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jamilya Kaibullayeva, PhD

Role: STUDY_DIRECTOR

KSSSID

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Primary Health Clinic #5

Almaty, , Kazakhstan

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Kazakhstan

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jamilya Kaibullayeva, PhD

Role: CONTACT

+77471051195

Kanat Khazhidinov, M.Sc.

Role: CONTACT

+77074138263

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Jamilya Kaibullayeva, PhD

Role: primary

+77471051195

Ainash Tanabayeva, MD

Role: backup

+77016007565

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

KSSSID-052021

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Fecal Transplant for Crohn's Disease
NCT03078803 COMPLETED PHASE2